Bioactivity and molecular docking studies of some nickel complexes: New analogues for the treatment of Alzheimer, glaucoma and epileptic diseases.
Enzyme inhibition
Metabolic enzymes
Molecular docking
Nickel complexes
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
14
03
2020
revised:
28
04
2020
accepted:
28
06
2020
pubmed:
11
7
2020
medline:
19
3
2021
entrez:
11
7
2020
Statut:
ppublish
Résumé
The interaction of the coordination compounds with biological molecules resulted in the investigation of the drug potential of these molecules. In this study, enzyme inhibition of DSA (1-3) coordination compounds that were previously investigated for their anticancer and antibacterial properties was investigated. Also, DSA (1-3) had K
Identifiants
pubmed: 32650180
pii: S0045-2068(20)31363-8
doi: 10.1016/j.bioorg.2020.104066
pii:
doi:
Substances chimiques
Nickel
7OV03QG267
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104066Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflict of interest.